Literature DB >> 26662759

Massive septic pelvic osteolysis following revision total hip arthroplasty in a patient with sickle cell anemia: clinical presentation and review of the literature.

Panagiotis Korovessis1, Thomas Repantis2.   

Abstract

Total hip arthroplasty (THA) performed in patients with osteonecrosis, caused by sickle cell disease, carries a higher risk of medical and orthopedic complications, than those observed after THA for osteonecrosis related to other conditions. We report such a case of a male patient, who underwent one-stage revision hip arthroplasty due to septic cup loosening after primary cementless THA and later developed severe septic osteomyelitis of the ipsilateral hemipelvis that had a fatal outcome. The relative literature regarding loosening and infection after THA in patients with sickle cell disease is thoroughly reviewed.

Entities:  

Keywords:  Pelvic osteolysis; Pelvic osteomyelitis; Postoperative complications; Revision hip arthroplasty; Septic loosening; Sickle cell anemia/complications; Total hip arthroplasty

Year:  2011        PMID: 26662759     DOI: 10.1007/s00590-011-0875-x

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  21 in total

1.  Acetabular roof reinforcement rings.

Authors:  P Korovessis; P Spastris; G Sdougos; P Salonikides; G Christodoulou; G Katsoudas
Journal:  Clin Orthop Relat Res       Date:  1992-10       Impact factor: 4.176

2.  Perioperative complications in patients with sickle cell disease. An orthopedic perspective.

Authors:  M S Garden; R E Grant; S Jebraili
Journal:  Am J Orthop (Belle Mead NJ)       Date:  1996-05

3.  Hip arthroplasty in patients with sickle-cell haemoglobinopathy.

Authors:  M T Acurio; R J Friedman
Journal:  J Bone Joint Surg Br       Date:  1992-05

4.  Results and complications of total hip arthroplasties in patients with sickle-cell hemoglobinopathies. Role of cementless components.

Authors:  J M Hickman; P F Lachiewicz
Journal:  J Arthroplasty       Date:  1997-06       Impact factor: 4.757

5.  Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy.

Authors:  A R Bishop; J R Roberson; J R Eckman; L L Fleming
Journal:  J Bone Joint Surg Am       Date:  1988-07       Impact factor: 5.284

6.  Concept and material properties of a cementless hip prosthesis system with Al2O3 ceramic ball heads and wrought Ti-6Al-4V stems.

Authors:  K Zweymüller; M Semlitsch
Journal:  Arch Orthop Trauma Surg       Date:  1982

7.  Acute infarction of long bones in children with sickle cell anemia.

Authors:  K Keeley; G R Buchanan
Journal:  J Pediatr       Date:  1982-08       Impact factor: 4.406

8.  Total hip arthroplasty in sickle cell hemoglobinopathy.

Authors:  M C Moran; M H Huo; K L Garvin; P M Pellicci; E A Salvati
Journal:  Clin Orthop Relat Res       Date:  1993-09       Impact factor: 4.176

9.  Total THA in adult osteonecrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Sebastien Zilber; Paolo Filippini; Gilles Mathieu; Alexandre Poignard; Frederic Galacteros
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

10.  Management of deep infection of total hip replacement.

Authors:  H W Buchholz; R A Elson; E Engelbrecht; H Lodenkämper; J Röttger; A Siegel
Journal:  J Bone Joint Surg Br       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.